Literature DB >> 28163002

Novel mutations in cervical cancer.

Talha Khan Burki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28163002     DOI： 10.1016/S1470-2045(17)30080-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Analysis of related risk factors of lung metastasis after laparoscopic radical hysterectomy of cervical cancer.

Authors:  Liu Henglian; Wang Jiajun; Wang Caixia; Lu Gang; Xia Min
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

2.  Mechanism underlying long non‑coding RNA ILF3‑AS1‑mediated inhibition of cervical cancer cell proliferation, invasion and migration, and promotion of apoptosis.

Authors:  Linmei Zhu; Ruixia Chen; Chunlin Jiang; Qingsheng Xie; Wenshuai Zhao; Xiaohong Gao; Haiming Huang
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

3.  EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.

Authors:  Juanhong Zhao; Haixia Li; Miao Yuan
Journal:  Genes Genomics       Date:  2021-03-09       Impact factor: 1.839
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.